28473083|t|ACR Appropriateness Criteria (Â®) Radiologic Management of Mesenteric Ischemia
28473083|a|Mesenteric vascular insufficiency is a serious medical condition that may lead to bowel infarction, morbidity, and mortality that may approach 50%. Recommended therapy for acute mesenteric ischemia includes aspiration embolectomy, transcatheter thrombolysis, and angioplasty with or without stenting for the treatment of underlying arterial stenosis. Nonocclusive mesenteric ischemia may respond to transarterial infusion of vasodilators such as nitroglycerin, papaverine, glucagon, and prostaglandin E1. Recommended therapy for chronic mesenteric ischemia includes angioplasty with or without stent placement and, if an endovascular approach is not possible, surgical bypass or endarterectomy. The diagnosis of median arcuate ligament syndrome is controversial, but surgical release may be appropriate depending on the clinical situation. Venous mesenteric ischemia may respond to systemic anticoagulation alone. Transhepatic or transjugular superior mesenteric vein catheterization and thrombolytic infusion can be offered depending on the severity of symptoms, condition of the patient, and response to systemic anticoagulation. Adjunct transjugular intrahepatic portosystemic shunt creation can be considered for outflow improvement. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND / UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
28473083	0	3	ACR	T094	C1515941
28473083	4	28	Appropriateness Criteria	T078	C0243161
28473083	33	43	Radiologic	T169	C0205483
28473083	44	54	Management	T058	C0376636
28473083	58	77	Mesenteric Ischemia	T047	C1412000
28473083	78	111	Mesenteric vascular insufficiency	T047	C1412000
28473083	125	142	medical condition	T033	C3843040
28473083	160	176	bowel infarction	T047	C0241950
28473083	178	187	morbidity	T081	C0026538
28473083	193	202	mortality	T081	C0178686
28473083	212	220	approach	T082	C0449445
28473083	238	245	therapy	T061	C0087111
28473083	250	275	acute mesenteric ischemia	T047	C0001363
28473083	285	295	aspiration	T061	C0349707
28473083	296	307	embolectomy	T061	C0162575
28473083	309	322	transcatheter	T061	C0203005
28473083	323	335	thrombolysis	T061	C0040044
28473083	341	352	angioplasty	T061	C0162577
28473083	369	377	stenting	T061	C2348535
28473083	386	395	treatment	T061	C0087111
28473083	410	427	arterial stenosis	T190	C0238397
28473083	429	461	Nonocclusive mesenteric ischemia	T047	C3852986
28473083	477	499	transarterial infusion	T061	C0021439
28473083	503	515	vasodilators	T121	C0042402
28473083	524	537	nitroglycerin	T109,T121	C0017887
28473083	539	549	papaverine	T109,T121	C0030350
28473083	551	559	glucagon	T116,T121,T125	C0017687
28473083	565	581	prostaglandin E1	T109,T121	C0002335
28473083	595	602	therapy	T061	C0087111
28473083	607	634	chronic mesenteric ischemia	T047	C0311262
28473083	644	655	angioplasty	T061	C0162577
28473083	672	687	stent placement	T061	C0522776
28473083	699	720	endovascular approach	T061	C1997114
28473083	738	753	surgical bypass	T061	C1536078
28473083	757	771	endarterectomy	T061	C0014098
28473083	777	786	diagnosis	T033	C0011900
28473083	790	822	median arcuate ligament syndrome	T047	C1861783
28473083	845	853	surgical	T061	C0543467
28473083	898	916	clinical situation	T080	C0018759
28473083	918	924	Venous	T082	C0348013
28473083	925	944	mesenteric ischemia	T047	C1412000
28473083	960	968	systemic	T169	C0205373
28473083	969	984	anticoagulation	T061	C0003281
28473083	992	1004	Transhepatic	T082	C0589464
28473083	1008	1020	transjugular	T082	C1254362
28473083	1021	1045	superior mesenteric vein	T023	C0226742
28473083	1046	1087	catheterization and thrombolytic infusion	T060	C2025545
28473083	1132	1140	symptoms	T184	C1457887
28473083	1142	1166	condition of the patient	T033	C0683521
28473083	1172	1180	response	T032	C0871261
28473083	1184	1192	systemic	T169	C0205373
28473083	1193	1208	anticoagulation	T061	C0003281
28473083	1210	1217	Adjunct	T169	C1719882
28473083	1218	1272	transjugular intrahepatic portosystemic shunt creation	T061	C0339897
28473083	1303	1314	improvement	T077	C2986411
28473083	1320	1349	American College of Radiology	T094	C1515941
28473083	1350	1374	Appropriateness Criteria	T078	C0243161
28473083	1379	1393	evidence-based	T169	C1510541
28473083	1394	1404	guidelines	T170	C0162791
28473083	1418	1437	clinical conditions	T033	C0683521
28473083	1447	1455	reviewed	T080	C1709940
28473083	1456	1464	annually	T079	C0332181
28473083	1470	1500	multidisciplinary expert panel	T097	C1319406
28473083	1506	1515	guideline	T170	C0162791
28473083	1516	1527	development	T169	C1527148
28473083	1532	1540	revision	T079	C0439617
28473083	1552	1570	extensive analysis	T062	C0936012
28473083	1582	1600	medical literature	T078	C0025120
28473083	1606	1628	peer-reviewed journals	T170	C2985503
28473083	1669	1682	methodologies	T062	C0086912
28473083	1684	1688	RAND	T170	C3826892
28473083	1691	1695	UCLA	T170	C4285296
28473083	1696	1711	Appropriateness	T080	C0814634
28473083	1723	1789	Grading of Recommendations Assessment, Development, and Evaluation	T170	C0282574
28473083	1793	1798	GRADE	T170	C0282574
28473083	1812	1827	appropriateness	T080	C0814634
28473083	1831	1838	imaging	T060	C0079595
28473083	1843	1863	treatment procedures	T061	C0087111
28473083	1877	1885	clinical	T080	C0205210
28473083	1886	1895	scenarios	T169	C0683579
28473083	1906	1915	instances	T078	C1550608
28473083	1922	1930	evidence	T078	C3887511
28473083	1934	1941	lacking	T080	C0332268
28473083	1945	1954	equivocal	T080	C0332241
28473083	1956	1970	expert opinion	T077	C0600219
28473083	1975	1985	supplement	T169	C2348609
28473083	2000	2008	evidence	T078	C3887511
28473083	2022	2029	imaging	T060	C0079595
28473083	2033	2042	treatment	T061	C0087111